Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain.

Luo G, Chen L, Easton A, Newton A, Bourin C, Shields E, Mosure K, Soars MG, Knox RJ, Matchett M, Pieschl RL, Post-Munson DJ, Wang S, Herrington J, Graef J, Newberry K, Sivarao DV, Senapati A, Bristow LJ, Meanwell NA, Thompson LA, Dzierba C.

J Med Chem. 2019 Feb 28;62(4):2213. doi: 10.1021/acs.jmedchem.9b00202. Epub 2019 Feb 8. No abstract available.

PMID:
30734560
2.

Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors.

Wu YJ, Venables B, Guernon J, Chen J, Sit SY, Rajamani R, Knox RJ, Matchett M, Pieschl RL, Herrington J, Bristow LJ, Meanwell NA, Thompson LA, Dzierba C.

Bioorg Med Chem Lett. 2019 Feb 15;29(4):659-663. doi: 10.1016/j.bmcl.2018.12.013. Epub 2018 Dec 6.

PMID:
30638874
3.

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain.

Luo G, Chen L, Easton A, Newton A, Bourin C, Shields E, Mosure K, Soars MG, Knox RJ, Matchett M, Pieschl RL, Post-Munson DJ, Wang S, Herrington J, Graef J, Newberry K, Sivarao DV, Senapati A, Bristow LJ, Meanwell NA, Thompson LA, Dzierba C.

J Med Chem. 2019 Jan 24;62(2):831-856. doi: 10.1021/acs.jmedchem.8b01550. Epub 2019 Jan 8. Erratum in: J Med Chem. 2019 Feb 28;62(4):2213.

PMID:
30576602
4.

Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.

Wu YJ, Guernon J, McClure A, Venables B, Rajamani R, Robbins KJ, Knox RJ, Matchett M, Pieschl RL, Herrington J, Bristow LJ, Meanwell NA, Olson R, Thompson LA, Dzierba C.

Bioorg Med Chem Lett. 2018 Mar 1;28(5):958-962. doi: 10.1016/j.bmcl.2018.01.035. Epub 2018 Feb 1.

PMID:
29439904
5.

Factors Influencing Uptake of Sylvatic Plague Vaccine Baits by Prairie Dogs.

Abbott RC, Russell RE, Richgels KLD, Tripp DW, Matchett MR, Biggins DE, Rocke TE.

Ecohealth. 2018 Mar;15(1):12-22. doi: 10.1007/s10393-017-1294-1. Epub 2017 Nov 20.

PMID:
29159477
6.

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation.

Wu YJ, Guernon J, McClure A, Luo G, Rajamani R, Ng A, Easton A, Newton A, Bourin C, Parker D, Mosure K, Barnaby O, Soars MG, Knox RJ, Matchett M, Pieschl R, Herrington J, Chen P, Sivarao DV, Bristow LJ, Meanwell NA, Bronson J, Olson R, Thompson LA, Dzierba C.

Bioorg Med Chem. 2017 Oct 15;25(20):5490-5505. doi: 10.1016/j.bmc.2017.08.012. Epub 2017 Aug 9.

PMID:
28818462
7.

Sylvatic Plague Vaccine Partially Protects Prairie Dogs (Cynomys spp.) in Field Trials.

Rocke TE, Tripp DW, Russell RE, Abbott RC, Richgels KLD, Matchett MR, Biggins DE, Griebel R, Schroeder G, Grassel SM, Pipkin DR, Cordova J, Kavalunas A, Maxfield B, Boulerice J, Miller MW.

Ecohealth. 2017 Sep;14(3):438-450. doi: 10.1007/s10393-017-1253-x. Epub 2017 Jun 22.

8.

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain.

Wu YJ, Guernon J, Shi J, Ditta J, Robbins KJ, Rajamani R, Easton A, Newton A, Bourin C, Mosure K, Soars MG, Knox RJ, Matchett M, Pieschl RL, Post-Munson DJ, Wang S, Herrington J, Graef J, Newberry K, Bristow LJ, Meanwell NA, Olson R, Thompson LA, Dzierba C.

J Med Chem. 2017 Mar 23;60(6):2513-2525. doi: 10.1021/acs.jmedchem.6b01918. Epub 2017 Mar 10.

PMID:
28234467
9.

Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

Hill MD, Fang H, Brown JM, Molski T, Easton A, Han X, Miller R, Hill-Drzewi M, Gallagher L, Matchett M, Gulianello M, Balakrishnan A, Bertekap RL, Santone KS, Whiterock VJ, Zhuo X, Bronson JJ, Macor JE, Degnan AP.

ACS Med Chem Lett. 2016 Oct 3;7(12):1082-1086. eCollection 2016 Dec 8.

10.

Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.

Cook J, Zusi FC, McDonald IM, King D, Hill MD, Iwuagwu C, Mate RA, Fang H, Zhao R, Wang B, Cutrone J, Ma B, Gao Q, Knox RJ, Matchett M, Gallagher L, Ferrante M, Post-Munson D, Molski T, Easton A, Miller R, Jones K, Digavalli S, Healy F, Lentz K, Benitex Y, Clarke W, Natale J, Siuciak JA, Lodge N, Zaczek R, Denton R, Morgan D, Bristow LJ, Macor JE, Olson RE.

J Med Chem. 2016 Dec 22;59(24):11171-11181. doi: 10.1021/acs.jmedchem.6b01506. Epub 2016 Dec 13.

PMID:
27958732
11.

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box.

Huang H, Degnan AP, Balakrishnan A, Easton A, Gulianello M, Huang Y, Matchett M, Mattson G, Miller R, Santone KS, Senapati A, Shields EE, Sivarao DV, Snyder LB, Westphal R, Whiterock VJ, Yang F, Bronson JJ, Macor JE.

Bioorg Med Chem Lett. 2016 Sep 1;26(17):4165-9. doi: 10.1016/j.bmcl.2016.07.065. Epub 2016 Jul 28.

PMID:
27496211
12.

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.

Yang F, Snyder LB, Balakrishnan A, Brown JM, Sivarao DV, Easton A, Fernandes A, Gulianello M, Hanumegowda UM, Huang H, Huang Y, Jones KM, Li YW, Matchett M, Mattson G, Miller R, Santone KS, Senapati A, Shields EE, Simutis FJ, Westphal R, Whiterock VJ, Bronson JJ, Macor JE, Degnan AP.

ACS Med Chem Lett. 2016 Jan 4;7(3):289-93. doi: 10.1021/acsmedchemlett.5b00450. eCollection 2016 Mar 10.

13.

Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.

Eisenhauer TD, Matchett M, Heasley R, Morton T, Devarakonda K, Giuliani M, Young JL, Barrett T.

Drug Dev Ind Pharm. 2016 Jan;42(1):157-165. Epub 2015 Jul 6.

PMID:
26146769
14.

Design of an automated enhanced-throughput platform for functional characterization of positive allosteric modulator-induced leftward shifts in apparent agonist potency in vitro.

Hendricson A, Matchett M, Ferrante M, Ferrante C, Hunnicutt E, Westphal R, Kostich W, Huang Y, Masias N, Hong D, Bertekap R, Burford N, Watson J, Alt A, Myslik J, Zhang L, Knox R.

J Lab Autom. 2012 Apr;17(2):104-15. doi: 10.1177/2211068211435301. Epub 2012 Feb 1.

PMID:
22357567
15.

Evaluation and optimization of compound solubilization and delivery methods in a two-tiered ion channel lead optimization triage.

Hendricson AW, Gallagher L, Matchett M, Ferrante M, Spence S, Paiva T, Shou W, Tertyshnikova S, Krambis M, Post-Munson D, Zhang L, Knox R.

Assay Drug Dev Technol. 2012 Apr;10(2):202-11. doi: 10.1089/adt.2011.0385. Epub 2011 Nov 15.

PMID:
22085018
16.

Personal factors that influence deaf college students' academic success.

Albertini JA, Kelly RR, Matchett MK.

J Deaf Stud Deaf Educ. 2012 Winter;17(1):85-101. doi: 10.1093/deafed/enr016. Epub 2011 May 9.

PMID:
21558157
17.

Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.

Kondo M, MacKinnon SL, Craft CC, Matchett MD, Hurta RA, Neto CC.

J Sci Food Agric. 2011 Mar 30;91(5):789-96. doi: 10.1002/jsfa.4330. Epub 2011 Feb 23.

PMID:
21351105
18.

Quality of life in pediatric patients with implantable cardioverter defibrillators.

Sears SF, Hazelton AG, St Amant J, Matchett M, Kovacs A, Vazquez LD, Fairbrother D, Redfearn S, Hanisch D, Dubin A, Cannon BC, Fishbach P, Kanter R, Bryant RM.

Am J Cardiol. 2011 Apr 1;107(7):1023-7. doi: 10.1016/j.amjcard.2010.11.027. Epub 2011 Jan 20.

PMID:
21256464
19.

Enzootic plague reduces black-footed ferret (Mustela nigripes) survival in Montana.

Matchett MR, Biggins DE, Carlson V, Powell B, Rocke T.

Vector Borne Zoonotic Dis. 2010 Jan-Feb;10(1):27-35. doi: 10.1089/vbz.2009.0053.

PMID:
20158329
20.

Cardiology Patient Page. Coping with my partner's ICD and cardiac disease.

Hazelton AG, Sears SF, Kirian K, Matchett M, Shea J.

Circulation. 2009 Sep 8;120(10):e73-6. doi: 10.1161/CIRCULATIONAHA.109.877613. No abstract available.

PMID:
19738146
21.

Effective management of ICD patient psychosocial issues and patient critical events.

Sears SF, Matchett M, Conti JB.

J Cardiovasc Electrophysiol. 2009 Nov;20(11):1297-304. doi: 10.1111/j.1540-8167.2009.01526.x. Epub 2009 Jun 26. Review.

PMID:
19563356
22.

The implantable cardioverter defibrillator: its history, current psychological impact and future.

Matchett M, Sears SF, Hazelton G, Kirian K, Wilson E, Nekkanti R.

Expert Rev Med Devices. 2009 Jan;6(1):43-50. doi: 10.1586/17434440.6.1.43. Review.

PMID:
19105779
23.

Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.

Broom DC, Matson DJ, Bradshaw E, Buck ME, Meade R, Coombs S, Matchett M, Ford KK, Yu W, Yuan J, Sun SH, Ochoa R, Krause JE, Wustrow DJ, Cortright DN.

J Pharmacol Exp Ther. 2008 Dec;327(3):620-33. doi: 10.1124/jpet.108.141853. Epub 2008 Sep 4.

PMID:
18772321
24.

No evidence of persistent Yersina pestis infection at prairie dog colonies in north-central Montana.

Holmes BE, Foresman KR, Matchett MR.

J Wildl Dis. 2006 Jan;42(1):164-9.

PMID:
16699160
25.

Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells.

Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RA.

Biochem Cell Biol. 2005 Oct;83(5):637-43.

PMID:
16234852
27.

The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons.

Ford KK, Matchett M, Krause JE, Yu W.

J Pharmacol Exp Ther. 2005 Oct;315(1):405-13. Epub 2005 Jul 13.

PMID:
16014755
28.
29.

The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.

Allen DL, Hoffman WP, Marder P, Matchett MR, Leiter PA, Abbott DL, Wolff RK.

J Pharmacol Exp Ther. 1996 Apr;277(1):341-9.

PMID:
8613940
30.

Chiral discrimination of phenethylamines with beta-cyclodextrin and heptakis(2,3-di-O-acetyl)beta-cyclodextrin by capillary electrophoresis and NMR spectroscopy.

Branch SK, Holzgrabe U, Jefferies TM, Mallwitz H, Matchett MW.

J Pharm Biomed Anal. 1994 Dec;12(12):1507-17.

PMID:
7696375
31.
32.

Lyophilized plasma as an assay standard for facfactor VIII: calibration and control with fresh plasma samples.

Hills M, Ingram GI, Matchett MO.

Br J Haematol. 1970 Jun;18(6):617-24. No abstract available.

PMID:
5428622
33.

Platelet function tests in thrombocythaemia and thrombocytosis.

McClure PD, Ingram GI, Stacey RS, Glass UH, Matchett MO.

Br J Haematol. 1966 Jul;12(4):478-98. No abstract available.

PMID:
5947984
35.

DISPOSABLE POLYSTYRENE BLOOD CLOTTING TUBES.

MATCHETT MO.

J Med Lab Technol. 1964 Jan;21:29-33. No abstract available.

PMID:
14107188
36.

The 'serial thrombin time' method for measuring fibrinogenolytic activity in plasma.

INGRAM GI, MATCHETT MO.

Nature. 1960 Nov 19;188:674-5. No abstract available.

PMID:
13717712
37.
38.

Experiments on the 'bridge effect.

INGRAM GI, TANNER EI, MATCHETT MO.

Br J Haematol. 1959 Jul;5:307-18. No abstract available.

PMID:
13852857

Supplemental Content

Loading ...
Support Center